,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destinybreast04', 'destiny,breast,4', 'breast']
standing ovation for the incredible results of the #destinybreast04 trial for her2 low breast cancer. #asco2022 #makingcancerhistory 
IM Resident @metrohealthCLE| @cwru Case Western Reserve Uni| Aspiring Oncologist | Special interest in Oncderm & Melanoma| ????????